MedTrace Logo

Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants

NCT02389491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-11-10

No results posted yet for this study

Summary

The purpose of this study is to explore the effects of high density formula in early postoperative infants with congenital heart disease and to assess its safety.

Conditions

  • Congenital Heart Disease

Interventions

DIETARY_SUPPLEMENT

normal density formula (Necocate)

In control group,there are 32 infants

DIETARY_SUPPLEMENT

high density formula(Infatrini)

In intervention group,there are 32 infants

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Gu Ying, docter · Children Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389491 on ClinicalTrials.gov